| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_89df47eebdbd10cd167389a5c2cb7e02 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0017
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-365
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N43-90
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P33-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P33-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7048
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P33-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-429
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-175 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P33-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-429 |
| filingDate |
2013-12-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6e352db81734a3eef66a9a4a2634f8fb |
| publicationDate |
2017-07-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
BR-112015014266-A2 |
| titleOfInvention |
transdermal parasiticidal formulations |
| abstract |
Patent Summary: "Transdermal Parasiticidal Formulations". The present invention relates to transdermal parasiticidal formulations and methods of treatment and use, wherein the formulation is not only capable of delivering an agent or agents through the skin layer, but is capable of delivering it through the wool layer. dirt and / or sebum from the skin if such a layer is present. The transdermal parasiticidal formulation may be a solution including a therapeutically effective amount of acarisol anthelmintic agent dissolved in a solution including isopropyl myristate and d-limonene. This base formulation is highly compatible with other compounds and various other actives may be added to this formulation. |
| priorityDate |
2012-12-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |